NCT01436201View on ClinicalTrials.gov

A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Digoxin

Administered orally

BIOLOGICAL

Dulaglutide

Administered as subcutaneous injection

Trial Locations (1)

32117

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01436201 - A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants | Biotech Hunter | Biotech Hunter